Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.52
-0.28 (-3.18%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Immix Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $19.75. The average 1-year stock price forecast is 131.81% higher than the current stock price, while the lowest is $14.5 (+70.19%) and the highest is $27 (+216.90%).
Price Target: $19.75 (+131.81%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immix Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 4 |
| Buy | 0 | 0 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 4 | 4 | 4 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Initiates $21 | Buy | Initiates | $21 | +146.48% | Jul 22, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +76.06% | Jul 22, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Initiates $27 | Buy | Initiates | $27 | +216.90% | Jun 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $19 | Buy | Initiates | $19 | +123.00% | Jun 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 → $20 | Buy | Reiterates | $15 → $20 | +134.74% | May 22, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
37.61M
EPS This Year
-0.71
from -0.89
EPS Next Year
-0.84
from -0.71
EPS and Forward PE are based on non-GAAP adjusted numbers.